The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

類似資料

• The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
  著者:: Wan, Marilyn T., 等
  出版事項: (2020)
• Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
  著者:: Syed, Maha N., 等
  出版事項: (2021)
• Evaluation of the Frequency of “Not Relevant” Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis
  著者:: Barbieri, John S., 等
  出版事項: (2020)
• Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
  著者:: Wan, Marilyn T., 等
  出版事項: (2020)
• The Fundamental Pivot of Strategic Decision Making: Creativity
  著者:: Arastoo Towhidi
  出版事項: (2011-02-01)